Colesterolo e rischio cardiovascolare: Percorso diagnostico-terapeutico in Italia

Michele Massimo Gulizia, Furio Colivicchi, Gualtiero Ricciardi, Simona Giampaoli, Aldo Pietro Maggioni, Maurizio Averna, Maria Stella Graziani, Ferruccio Ceriotti, Alessandro Mugelli, Francesco Rossi, Gerardo Medea, Damiano Parretti, Maurizio Giuseppe Abrignani, Marcello Arca, Pasquale Perrone Filardi, Francesco Perticone, Alberico Catapano, Raffaele Griffo, Federico Nardi, Carmine RiccioAndrea Di Lenarda, Marino Scherillo, Nicoletta Musacchio, Antonio Vittorio Panno, Giovanni Battista Zito, Mauro Campanini, Leonardo Bolognese, Pompilio Massimo Faggiano, Giuseppe Musumeci, Enrico Pusineri, Marcello Ciaccio, Enzo Bonora, Giorgio Cantelli Forti, Maria Pia Ruggieri, Claudio Cricelli, Francesco Romeo, Roberto Ferrari, Attilio Maseri

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Atherosclerotic cardiovascular disease still represents the leading cause of death in western countries. A wealth of scientific evidence demonstrates that increased blood cholesterol levels have a major impact on the outbreak and progression of atherosclerotic plaques. Moreover, several cholesterol-lowering pharmacological agents, including statins and ezetimibe, have proven effective in improving clinical outcomes. This document is focused on the clinical management of hypercholesterolemia and has been conceived by 16 Italian medical associations with the support of the Italian National Institute of Health. The authors have considered with particular attention the role of hypercholesterolemia in the genesis of atherosclerotic cardiovascular disease. Besides, the implications of high cholesterol levels in the definition of the individual cardiovascular risk profile have been carefully analyzed, while all available therapeutic options for blood cholesterol reduction and cardiovascular risk mitigation have been considered. Finally, this document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolemia.

Original languageItalian
Pages (from-to)3S-57S
JournalGiornale Italiano di Cardiologia
Volume17
Issue number6
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Gulizia, M. M., Colivicchi, F., Ricciardi, G., Giampaoli, S., Maggioni, A. P., Averna, M., ... Maseri, A. (2016). Colesterolo e rischio cardiovascolare: Percorso diagnostico-terapeutico in Italia. Giornale Italiano di Cardiologia, 17(6), 3S-57S.

Colesterolo e rischio cardiovascolare : Percorso diagnostico-terapeutico in Italia. / Gulizia, Michele Massimo; Colivicchi, Furio; Ricciardi, Gualtiero; Giampaoli, Simona; Maggioni, Aldo Pietro; Averna, Maurizio; Graziani, Maria Stella; Ceriotti, Ferruccio; Mugelli, Alessandro; Rossi, Francesco; Medea, Gerardo; Parretti, Damiano; Abrignani, Maurizio Giuseppe; Arca, Marcello; Filardi, Pasquale Perrone; Perticone, Francesco; Catapano, Alberico; Griffo, Raffaele; Nardi, Federico; Riccio, Carmine; Di Lenarda, Andrea; Scherillo, Marino; Musacchio, Nicoletta; Panno, Antonio Vittorio; Zito, Giovanni Battista; Campanini, Mauro; Bolognese, Leonardo; Faggiano, Pompilio Massimo; Musumeci, Giuseppe; Pusineri, Enrico; Ciaccio, Marcello; Bonora, Enzo; Forti, Giorgio Cantelli; Ruggieri, Maria Pia; Cricelli, Claudio; Romeo, Francesco; Ferrari, Roberto; Maseri, Attilio.

In: Giornale Italiano di Cardiologia, Vol. 17, No. 6, 2016, p. 3S-57S.

Research output: Contribution to journalArticle

Gulizia, MM, Colivicchi, F, Ricciardi, G, Giampaoli, S, Maggioni, AP, Averna, M, Graziani, MS, Ceriotti, F, Mugelli, A, Rossi, F, Medea, G, Parretti, D, Abrignani, MG, Arca, M, Filardi, PP, Perticone, F, Catapano, A, Griffo, R, Nardi, F, Riccio, C, Di Lenarda, A, Scherillo, M, Musacchio, N, Panno, AV, Zito, GB, Campanini, M, Bolognese, L, Faggiano, PM, Musumeci, G, Pusineri, E, Ciaccio, M, Bonora, E, Forti, GC, Ruggieri, MP, Cricelli, C, Romeo, F, Ferrari, R & Maseri, A 2016, 'Colesterolo e rischio cardiovascolare: Percorso diagnostico-terapeutico in Italia', Giornale Italiano di Cardiologia, vol. 17, no. 6, pp. 3S-57S.
Gulizia MM, Colivicchi F, Ricciardi G, Giampaoli S, Maggioni AP, Averna M et al. Colesterolo e rischio cardiovascolare: Percorso diagnostico-terapeutico in Italia. Giornale Italiano di Cardiologia. 2016;17(6):3S-57S.
Gulizia, Michele Massimo ; Colivicchi, Furio ; Ricciardi, Gualtiero ; Giampaoli, Simona ; Maggioni, Aldo Pietro ; Averna, Maurizio ; Graziani, Maria Stella ; Ceriotti, Ferruccio ; Mugelli, Alessandro ; Rossi, Francesco ; Medea, Gerardo ; Parretti, Damiano ; Abrignani, Maurizio Giuseppe ; Arca, Marcello ; Filardi, Pasquale Perrone ; Perticone, Francesco ; Catapano, Alberico ; Griffo, Raffaele ; Nardi, Federico ; Riccio, Carmine ; Di Lenarda, Andrea ; Scherillo, Marino ; Musacchio, Nicoletta ; Panno, Antonio Vittorio ; Zito, Giovanni Battista ; Campanini, Mauro ; Bolognese, Leonardo ; Faggiano, Pompilio Massimo ; Musumeci, Giuseppe ; Pusineri, Enrico ; Ciaccio, Marcello ; Bonora, Enzo ; Forti, Giorgio Cantelli ; Ruggieri, Maria Pia ; Cricelli, Claudio ; Romeo, Francesco ; Ferrari, Roberto ; Maseri, Attilio. / Colesterolo e rischio cardiovascolare : Percorso diagnostico-terapeutico in Italia. In: Giornale Italiano di Cardiologia. 2016 ; Vol. 17, No. 6. pp. 3S-57S.
@article{210cccfa104f41598ba23612dde32ad6,
title = "Colesterolo e rischio cardiovascolare: Percorso diagnostico-terapeutico in Italia",
abstract = "Atherosclerotic cardiovascular disease still represents the leading cause of death in western countries. A wealth of scientific evidence demonstrates that increased blood cholesterol levels have a major impact on the outbreak and progression of atherosclerotic plaques. Moreover, several cholesterol-lowering pharmacological agents, including statins and ezetimibe, have proven effective in improving clinical outcomes. This document is focused on the clinical management of hypercholesterolemia and has been conceived by 16 Italian medical associations with the support of the Italian National Institute of Health. The authors have considered with particular attention the role of hypercholesterolemia in the genesis of atherosclerotic cardiovascular disease. Besides, the implications of high cholesterol levels in the definition of the individual cardiovascular risk profile have been carefully analyzed, while all available therapeutic options for blood cholesterol reduction and cardiovascular risk mitigation have been considered. Finally, this document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolemia.",
keywords = "Atherosclerosis, Diagnostic and therapeutic pathways, Hypercholesterolemia, PCSK9 inhibitors, Statins, Sustainable healthcare",
author = "Gulizia, {Michele Massimo} and Furio Colivicchi and Gualtiero Ricciardi and Simona Giampaoli and Maggioni, {Aldo Pietro} and Maurizio Averna and Graziani, {Maria Stella} and Ferruccio Ceriotti and Alessandro Mugelli and Francesco Rossi and Gerardo Medea and Damiano Parretti and Abrignani, {Maurizio Giuseppe} and Marcello Arca and Filardi, {Pasquale Perrone} and Francesco Perticone and Alberico Catapano and Raffaele Griffo and Federico Nardi and Carmine Riccio and {Di Lenarda}, Andrea and Marino Scherillo and Nicoletta Musacchio and Panno, {Antonio Vittorio} and Zito, {Giovanni Battista} and Mauro Campanini and Leonardo Bolognese and Faggiano, {Pompilio Massimo} and Giuseppe Musumeci and Enrico Pusineri and Marcello Ciaccio and Enzo Bonora and Forti, {Giorgio Cantelli} and Ruggieri, {Maria Pia} and Claudio Cricelli and Francesco Romeo and Roberto Ferrari and Attilio Maseri",
year = "2016",
language = "Italian",
volume = "17",
pages = "3S--57S",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "6",

}

TY - JOUR

T1 - Colesterolo e rischio cardiovascolare

T2 - Percorso diagnostico-terapeutico in Italia

AU - Gulizia, Michele Massimo

AU - Colivicchi, Furio

AU - Ricciardi, Gualtiero

AU - Giampaoli, Simona

AU - Maggioni, Aldo Pietro

AU - Averna, Maurizio

AU - Graziani, Maria Stella

AU - Ceriotti, Ferruccio

AU - Mugelli, Alessandro

AU - Rossi, Francesco

AU - Medea, Gerardo

AU - Parretti, Damiano

AU - Abrignani, Maurizio Giuseppe

AU - Arca, Marcello

AU - Filardi, Pasquale Perrone

AU - Perticone, Francesco

AU - Catapano, Alberico

AU - Griffo, Raffaele

AU - Nardi, Federico

AU - Riccio, Carmine

AU - Di Lenarda, Andrea

AU - Scherillo, Marino

AU - Musacchio, Nicoletta

AU - Panno, Antonio Vittorio

AU - Zito, Giovanni Battista

AU - Campanini, Mauro

AU - Bolognese, Leonardo

AU - Faggiano, Pompilio Massimo

AU - Musumeci, Giuseppe

AU - Pusineri, Enrico

AU - Ciaccio, Marcello

AU - Bonora, Enzo

AU - Forti, Giorgio Cantelli

AU - Ruggieri, Maria Pia

AU - Cricelli, Claudio

AU - Romeo, Francesco

AU - Ferrari, Roberto

AU - Maseri, Attilio

PY - 2016

Y1 - 2016

N2 - Atherosclerotic cardiovascular disease still represents the leading cause of death in western countries. A wealth of scientific evidence demonstrates that increased blood cholesterol levels have a major impact on the outbreak and progression of atherosclerotic plaques. Moreover, several cholesterol-lowering pharmacological agents, including statins and ezetimibe, have proven effective in improving clinical outcomes. This document is focused on the clinical management of hypercholesterolemia and has been conceived by 16 Italian medical associations with the support of the Italian National Institute of Health. The authors have considered with particular attention the role of hypercholesterolemia in the genesis of atherosclerotic cardiovascular disease. Besides, the implications of high cholesterol levels in the definition of the individual cardiovascular risk profile have been carefully analyzed, while all available therapeutic options for blood cholesterol reduction and cardiovascular risk mitigation have been considered. Finally, this document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolemia.

AB - Atherosclerotic cardiovascular disease still represents the leading cause of death in western countries. A wealth of scientific evidence demonstrates that increased blood cholesterol levels have a major impact on the outbreak and progression of atherosclerotic plaques. Moreover, several cholesterol-lowering pharmacological agents, including statins and ezetimibe, have proven effective in improving clinical outcomes. This document is focused on the clinical management of hypercholesterolemia and has been conceived by 16 Italian medical associations with the support of the Italian National Institute of Health. The authors have considered with particular attention the role of hypercholesterolemia in the genesis of atherosclerotic cardiovascular disease. Besides, the implications of high cholesterol levels in the definition of the individual cardiovascular risk profile have been carefully analyzed, while all available therapeutic options for blood cholesterol reduction and cardiovascular risk mitigation have been considered. Finally, this document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolemia.

KW - Atherosclerosis

KW - Diagnostic and therapeutic pathways

KW - Hypercholesterolemia

KW - PCSK9 inhibitors

KW - Statins

KW - Sustainable healthcare

UR - http://www.scopus.com/inward/record.url?scp=84978835838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978835838&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84978835838

VL - 17

SP - 3S-57S

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 6

ER -